000 | 01175 a2200325 4500 | ||
---|---|---|---|
005 | 20250511143902.0 | ||
264 | 0 | _c19780814 | |
008 | 197808s 0 0 eng d | ||
022 | _a0009-8981 | ||
024 | 7 |
_a10.1016/0009-8981(78)90302-9 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBirkett, D J | |
245 | 0 | 0 |
_aThe fatty acid content and drug binding characteristics of commercial albumin preparations. _h[electronic resource] |
260 |
_bClinica chimica acta; international journal of clinical chemistry _cMay 1978 |
||
300 |
_a253-8 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article | ||
650 | 0 | 4 |
_aFatty Acids _xanalysis |
650 | 0 | 4 | _aFluorescent Dyes |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aIbuprofen |
650 | 0 | 4 | _aPhenylbutazone |
650 | 0 | 4 | _aProtein Binding |
650 | 0 | 4 | _aSarcosine |
650 | 0 | 4 |
_aSerum Albumin _xanalysis |
650 | 0 | 4 | _aSpectrometry, Fluorescence |
700 | 1 | _aMyers, S P | |
700 | 1 | _aSudlow, G | |
773 | 0 |
_tClinica chimica acta; international journal of clinical chemistry _gvol. 85 _gno. 3 _gp. 253-8 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/0009-8981(78)90302-9 _zAvailable from publisher's website |
999 |
_c677884 _d677884 |